OTCMKTS:ANTB

(ANTB) (ANTB) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.81
$0.83
50-Day Range
N/A
52-Week Range
$0.75
$1.25
Volume
2,100 shs
Average Volume
8,783 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About (ANTB)

Rezolute, Inc. is biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. Its products portfolio include RZ358-Phase 2, an antibody for the ultra-orphan indication of congenital hyperInsulinism; AB101-Phase 1, a once-weekly injectable basal insulin; and RZ402 which targets diabetic macular edema. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada on July 26, 2010 and is headquartered in Redwood City, CA.

ANTB Stock News Headlines

“Retirement Secret” Showed 995% Gain Last Time We Shared It
Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.
Aerodrom Nikola Tesla ad AERO
“Retirement Secret” Showed 995% Gain Last Time We Shared It
Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.
Remarkable Roman ruins still standing
Beautiful Roman ruins everyone should see
Staggering Roman ruins still standing
See More Headlines
Receive ANTB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ANTB) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Internet Software & Services
Sub-Industry
N/A
Current Symbol
OTCMKTS:ANTB
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Nevan Charles Elam
    President, Chief Executive Officer, CFO & Director
  • Michael Deperro
    Head-Operations
  • Sankaram Mantripragada
    Chief Scientific Officer
  • Erin O’Boyle
    Head-Clinical Operations
  • Davelyn Hood
    Director-Scientific & Patient Affairs

ANTB Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of (ANTB) own?
This page (OTCMKTS:ANTB) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners